The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 13, 2021

Filed:

Jan. 18, 2019
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Joseph John Binder, San Diego, CA (US);

Paul Jason Cockle, Abingdon, GB;

Derek John Falconer, San Diego, CA (US);

Siradanahalli Guru, San Diego, CA (US);

Karin Ute Jooss, San Diego, CA (US);

Marianne Marcela Andrea Martinic, Bottmingen, CH;

Kenneth Nelson Wills, Carlsbad, CA (US);

Helen Kim Cho, San Diego, CA (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C12N 15/62 (2006.01); A61K 48/00 (2006.01); A61K 31/711 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 39/00117 (2018.08); A61K 39/001157 (2018.08); A61K 48/005 (2013.01); A61K 31/711 (2013.01); A61K 2039/53 (2013.01); A61K 2039/57 (2013.01); A61K 2039/575 (2013.01); A61K 2039/585 (2013.01); A61K 2039/70 (2013.01); C12N 15/62 (2013.01);
Abstract

The present disclosure provides (i) isolated immunogenic TAA polypeptides (i.e., an immunogenic MUC1 polypeptides, an immunogenic MSLN polypeptides, and an immunogenic TERT polypeptides), (ii) isolated nucleic acid molecules encoding one or more immunogenic TAA polypeptides, (iii) compositions comprising an immunogenic TAA polypeptide or an isolated nucleic acid molecule encoding an immunogenic TAA polypeptide, and (iv) methods relating to uses of the polypeptides, nucleic acid molecules, and compositions.


Find Patent Forward Citations

Loading…